Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses

Critical Care Medicine

Volumn 38, Issue 1, 2010, Pages 223-241

  McConnell, Kevin W ^a   McDunn, Jonathan E ^a   Clark, Andrew T ^a   Dunne, W Michael ^a   Dixon, David J ^a   Turnbull, Isaiah R ^a   Dipasco, Peter J ^a   Osberghaus, William F ^a   Sherman, Benjamin ^a   Martin, James R ^a   Walter, Michael J ^a   Cobb, J Perren ^a   Buchman, Timothy G ^a   Hotchkiss, Richard S ^a   Coopersmith, Craig M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Host response; Pneumonia; Pseudomonas aeruginosa; Sepsis; Streptococcus pneumoniae

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE CHEMOTACTIC PEPTIDE 1; MACROPHAGE INFLAMMATORY PEPTIDE 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR SR2; UNCLASSIFIED DRUG; AUTACOID; PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; LUNG LAVAGE; MICROARRAY ANALYSIS; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; SEPSIS; STREPTOCOCCUS PNEUMONIAE; ANIMAL; BLOOD; CYTOLOGY; DISEASE MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; MICROBIOLOGY; MOUSE STRAIN; NONPARAMETRIC TEST; PATHOGENICITY; PHYSIOLOGY; PROBABILITY; RANDOMIZATION; RISK FACTOR; STREPTOCOCCUS PNEUMONIA; SURVIVAL;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MICE; MICE, INBRED STRAINS; PEROXIDASE; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PROBABILITY; PSEUDOMONAS AERUGINOSA; RANDOM ALLOCATION; RISK FACTORS; STATISTICS, NONPARAMETRIC; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74049158154     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b4a76b     Document Type: Article

References (39)

1. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
3. Elson G, Dunn-Siegrist I, Daubeuf B, et al: Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109: 1574-1583
4. Foell D, Wittkowski H, Vogl T, et al: S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81: 28-37
5. Hoebe K, Janssen E, Beutler B: The interface between innate and adaptive immunity. Nat Immunol 2004; 5:971-974
6. Tang BM, McLean AS, Dawes IW, et al: Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Crit Care Med 2008; 36:1125-1128
7. Tang BM, McLean AS, Dawes IW, et al: Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009; 37:882-888
8. Deutschman CS, Konstantinides FN, Tsai M, et al: Physiology and metabolism in isolated viral septicemia. Further evidence of an organism-independent, host-dependent response. Arch Surg 1987; 122:21-25
9. Fry DE, Pearlstein L, Fulton RL, et al: Multiple system organ failure. The role of uncontrolled infection. Arch Surg 1980; 115: 136-140
10. Fry DE: The generic septic response. Crit Care Med 2008; 36:1369-1370
11. Rittirsch D, Hoesel LM, Ward PA: The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007; 81:137-143
12. Yu SL, Chen HW, Yang PC, et al: Differential gene expression in gram-negative and gram-positive sepsis. Am J Respir Crit Care Med 2004; 169:1135-1143
13. Feezor RJ, Oberholzer C, Baker HV, et al: Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun 2003; 71:5803-11583
14. Johnson SB, Lissauer M, Bochicchio GV, et al: Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg 2007; 245:611-621
15. Ramilo O, Allman W, Chung W, et al: Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007; 109:2066-2077
16. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037
17. National Nosocomial Infections Surveillance (NNIS): System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-532
18. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
19. Coopersmith CM, Stromberg PE, Davis CG, et al: Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 2003; 31:1630-1637
20. Vyas D, Robertson CM, Stromberg PE, et al: Epithelial apoptosis in mechanistically distinct methods of injury in the murine small intestine. Histol Histopathol 2007; 22: 623-630
21. Coopersmith CM, Stromberg PE, Dunne WM, et al: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 2002; 287: 1716-1721
22. Sheehan KC, Ruddle NH, Schreiber RD: Generation and characterization of hamster monoclonal antibodies that neutralize mu-rine tumor necrosis factors. J Immunol 1989; 142:3884-3893
23. Knight PR, Sreekumar A, Siddiqui J, et al: Development of a sensitive microarray im-munoassay and comparison with standard enzyme-linked immunoassay for cytokine analysis. Shock 2004; 21:26-30
24. Wells C, Hess D, Erlandsen S: Impact of the indigenous flora in animal models of shock and sepsis. Shock 2004; 22:562-568
25. Magnotti LJ, Upperman JS, Xu DZ, et al: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998; 228:518-527
26. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
27. McDunn JE, Husain KD, Polpitiya AD, et al: Plasticity of the Systemic Inflammatory Response to Acute Infection during Critical Illness: Development of the Riboleukogram. PLoS ONE 2008; 3:e1564
28. Eichacker PQ, Parent C, Kalil A, et al: Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 2002; 166:1197-1205
29. Panacek EA, Marshall JC, Albertson TE, et al: Efficacy and safety of the monoclonal antitumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004; 32:2173-2182
30. Reinhart K, Menges T, Gardlund B, et al: Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med 2001; 29:765-769
31. Karzai W, Cui X, Mehlhorn B, et al: Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats. Anesthesiology 2003; 99:81-89
32. Gomes RN, Figueiredo RT, Bozza FA, et al: Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production. Shock 2006; 26:457-463
33. Nau R, Eiffert H: Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections. FEMS Immunol Med Microbiol 2005; 44:1-16
34. Coopersmith CM, Amiot DM, Stromberg PE, et al: Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia. Shock 2003; 19:408-414
35. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
36. Branger J, Knapp S, Weijer S, et al: Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Im-mun 2004; 72:788-794 (Pubitemid 38166657)
37. Gingles NA, Alexander JE, Kadioglu A, et al: Role of genetic resistance in invasive pneu-mococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect Immun 2001; 69: 426-434
38. Prince AS, Mizgerd JP, Wiener-Kronish J, et al: Cell signaling underlying the pathophys-iology of pneumonia. Am J Physiol Lung Cell Mol Physiol 2006; 291:L297-L300
39. Zhuo H, Yang K, Lynch SV, et al: Increased mortality of ventilated patients with endotra-cheal Pseudomonas aeruginosa without clinical signs of infection. Crit Care Med 2008; 36:2495-2503